Post-earnings recap
Reported
Mon, Nov 6, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
TransMedics Group's earnings report showed a significant miss on EPS, which contributed to a 5.7% drop in the stock price. The lack of revenue figures and guidance has left investors uncertain about the company's future performance. Management's defensive tone suggests they are facing challenges that could impact growth.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.78 | N/A | -328.57% |
| Revenue | N/A | N/A | N/A |
Management's tone was defensive, highlighting ongoing challenges without offering specific guidance. They focused on navigating current market conditions.
Management did not provide specific revenue figures or guidance for the upcoming quarters.
The company acknowledged challenges in the current market environment.